World Blood Product (including Recombinant Proteins) Market Analysis Forecast 2020-2025

Publication Month: May 2020 | No. of Pages: 85 Published By: ICR World
Single User License: US $ 2960
Corporate User License: US $ 3800

Summary

The global Blood Product (including Recombinant Proteins) market is estimated to grow at an estimated growth rate 6.75% in the next 5 years and that will reach 38.55 billion USD in 2020. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Blood Product by different Type, region and application, in addition, this report introduces market competition situation among the companies and company profile, besides, market price analysis and value chain features are covered in this report.

Market Segment

Type

Albumin
Immune Globulin
Coagulation Factor
Others

Application

Hospital
Clinics
Others
Market Size by End Users
Market Forecast by End Users
Major Consumers by End Users
Different Situation by Region
Region North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Italy, Russia, etc.)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, etc.)
South America (Brazil, etc)
Middle East & Africa (Saudi Arabia, UAE, South Africa, etc.) Regional Output

Company
Shire (Takeda)
CSL
Grifols
Octapharma
BPL (Creat)
Kedrion
Biotest (Creat)
CBOP
RAAS (Creat)
Hualan Bio
Beijing Tiantan

Table of Content

Part 1 Industry Overview 1
1.1 Blood Product Industry 1
1.1.1 Overview 1
1.1.2 Development of Blood Product 3
1.2 Market Segment 4
1.2.1 Upstream 4
1.2.2 Downstream 7
1.3 Cost Analysis 8
Part 2 Industry Environment 11
2.1 Policy 11
2.2 Economics 11
2.3 Technology 14
Part 3 Blood Product Market by Type 15
3.1 Segment Overview 15
3.1.1 Albumin 15
3.1.2 Immune Globulin 16
3.1.3 Coagulation Factor 16
3.1.4 Specialty 17
3.2 Market Size 17
3.3 Market Forecast 20
Part 4 Blood Product Companies List 21
4.1 Shire (Takeda) 21
4.1.1 Company Profile 21
4.1.2 Product Picture and Specifications 22
4.1.3 Revenue and Gross Margin 24
4.2 CSL 24
4.2.1 Company Profile 24
4.2.2 Product Picture and Specifications 25
4.2.3 Revenue and Gross Margin 27
4.3 Grifols 27
4.3.1 Company Profile 27
4.3.2 Product Picture and Specifications 29
4.3.3 Revenue and Gross Margin 32
4.4 Octapharma 32
4.4.1 Company Profile 32
4.4.2 Product Picture and Specifications 34
4.4.3 Revenue and Gross Margin 36
4.5 BPL (Creat) 36
4.5.1 Company Profile 36
4.5.2 Product Picture 37
4.5.3 Revenue and Gross Margin 38
4.6 Kedrion 38
4.6.1 Company Profile 38
4.6.2 Product Picture 39
4.6.3 Revenue and Gross Margin 40
4.7 Biotest (Creat) 40
4.7.1 Company Profile 40
4.7.2 Revenue and Gross Margin 41
4.8 CBOP 41
4.8.1 Company Profile 41
4.8.2 Product Picture 43
4.8.3 Revenue and Gross Margin 43
4.9 RAAS (Creat) 43
4.9.1 Company Profile 43
4.9.2 Product Picture and Specifications 45
4.9.3 Revenue and Gross Margin 47
4.10 Hualan Bio 47
4.10.1 Company Profile 47
4.10.2 Product Picture and Specifications 50
4.10.3 Revenue and Gross Margin 52
4.11 Beijing Tiantan Bio 53
4.10.1 Company Profile 53
4.11.2 Product Picture and Specification 53
4.11.3 Revenue and Gross margin 53
Part 5 Market Competition 55
5.1 Companies Competition 55
5.2 Regional Concentration 57
5.3 Plant Locations by manufacturers 61
Part 6 Market Demand by Segment 63
6.1 Demand Situation 63
6.1.1 Demand in Hospital 63
6.1.2 Demand in Clinics 63
6.1.3 Demand in Others 63
6.2 Regional Demand Comparison 64
6.3 Consumer Distribution Overview 64
6.4 Demand Forecast 65
Part 7 Region Operation 66
7.1 Regional Production 66
7.2 Regional Market 67
7.2.1 North America 67
7.2.2 Europe 68
7.2.3 Asia-Pacific 69
7.2.4 South America 70
7.2.5 Middle East & Africa 71
7.2.6 South America and Middle East & Africa by Country 71
7.3 Regional Forecast 72
Part 8 Marketing & Price 74
8.1 Price and Margin 74
Manufacturers Gross Margin Analysis 74
8.2 Marketing Channel 75
Part 9 Research Conclusion 76
Data Source: 77



Tables and figures
Figure Constituents of Blood, Plasma, and Plasma Proteins 2
Figure Blood Product Industry Chain Structure 3
Figure Diagram of automated plasma collection procedure 4
Figure Number of US Blood Plasma Collection Centers 2007-2018 5
Figure US Plasma Collection Centers by Companies: Comparisons (2015 and Nov-2018) 6
Figure Number of Europe Blood Plasma Collection Centers 2007-2017 6
Table Application Segment of Blood Product 7
Table Global Blood Product Market 2015-2020E, by End Users, in USD Million 7
Table Plasma: Cost Components 8
Figure Manufacturing Process Analysis of Blood Product 9
Figure Manufacturing Cost Structure Analysis of Blood Product in 2018 10
Table Plasma Manufacturing Comparisons by Chinese Manufacturers and International Manufacturers 14
Table Specification Comparison of Different Types of Blood Product 15
Table Major Companies List of Albumin 15
Table Major Companies List of Immune Globulin 16
Table Major Companies List of Coagulation Factor 16
Table Major Companies List of Specialty 17
Table Blood Product Market 2015-2020E, by Type, in USD Million 17
Figure Albumin Market Growth 2015-2020E, in USD Million 18
Figure Immunoglobulin Market Growth 2015-2020E, in USD Million 18
Figure Coagulation Factor Market Growth 2015-2020E, in USD Million 19
Figure Specialty Market Growth 2015-2020E, in USD Million 19
Table Blood Product Market Size Forecast 2020E-2025F, by Type, in USD Million 20
Table Shire (Takeda) Company Profile List 21
Figure Albumin Product Picture of Shire (Takeda) 22
Figure Immune Globulin Product Picture of Shire (Takeda) 23
Table Blood Product Revenue, Gross Margin and Global Revenue market share of Shire (Takeda) 2018-2019 24
Table CSL Company Profile List 24
Figure Albumin Product Picture of CSL 25
Figure Immune Globulins Product Picture of CSL 26
Figure Coagulation Factors Product Picture of CSL 27
Table Blood Product Revenue, Gross Margin and Global Revenue market share of CSL 2018-2019 27
Table Grifols Company Profile List 27
Figure Grifols IVIG Flebogamma® 10% DIF Product 29
Table Grifols IVIG Flebogamma® 10% DIF Packaging Standards 29
Figure Grifols IVIG Flebogamma® 5% DIF Product 30
Table Grifols IVIG Flebogamma® 5% DIF Packaging Standards 31
Figure Albumin Product Picture of Grifols 31
Figure Coagulation Factors Product Picture of Grifols 32
Table Blood Product Revenue, Gross Margin and Global Revenue market share of Grifols 2018-2019 32
Table Octapharma Company Profile List 32
Figure Albumin Product Picture of Octapharma 34
Figure Immune Globulins Product Picture of Octapharma 35
Figure Coagulation Factors Product Picture of Octapharma 35
Table Blood Product Revenue, Gross Margin and Global Revenue market share of Octapharma 2018-2019 36
Table BPL Company Profile List 36
Figure Coagulation Factors Product Picture of BPL 37
Figure Albumin Product Picture of BPL 37
Figure Immunoglobulins Product Picture of BPL 37
Table Blood Product Revenue, Gross Margin and Global Revenue market share of BPL 2018-2019 38
Table Kedrion Company Profile List 38
Figure Albumin Product Picture of Kedrion 39
Figure Immune Globulins Product Picture of Kedrion 40
Table Blood Product Revenue, Gross Margin and Global Revenue market share of Kedrion 2018-2019 40
Table Blood Product Revenue, Gross Margin and Global Revenue market share of Biotest (Creat) 2018-2019 41
Table CBOP Company Profile List 41
Figure Blood Product Picture of CBOP 43
Table Blood Product Revenue, Gross Margin and Global Revenue market share of CBOP 2018-2019 43
Table RAAS Company Profile List 43
Figure Albumin Product Picture of RAAS 45
Figure Immune Globulins Product Picture of RAAS 46
Figure Coagulation Factors Product Picture of RAAS 46
Table Blood Product Revenue, Gross Margin and Global Revenue market share of RAAS 2018-2019 47
Table Hualan Bio Company Profile List 47
Figure IVIG Product Picture of Hualan Bio 50
Table Hualan Bio IVIG Standards 50
Figure Albumin Product Picture of Hualan Bio 51
Table Specifications of Albumin Product 51
Figure Coagulation Factors Product Picture of Hualan Bio 52
Table Blood Product Revenue, Gross Margin and Global Revenue market share of Hualan Bio 2018-2019 52
Figure Product Picture 53
Table Blood Product Revenue, Gross Margin and Global Revenue market share of Beijing Tiantan Bio 2018-2019 53
Table Global Blood Product Sales Revenue 2018-2019, by Companies, in USD Million 55
Table Global Blood Product Sales Revenue Share, 2018-2019, by Companies, in USD 56
Figure North America Blood Product Market Concentration in 2019 57
Figure Europe Blood Product Market Concentration in 2019 58
Figure Asia-Pacific Blood Product Market Concentration in 2019 59
Figure South America Blood Product Market Concentration in 2019 60
Figure Middle East & Africa Blood Product Market Concentration in 2019 61
Table Plant Locations by manufacturers 61
Table Blood Product Demand in Hospital 2015-2020E, in USD Million 63
Table Blood Product Demand in Clinics 2015-2020E, in USD Million 63
Table Blood Product Demand in Others 2015-2020E, in USD Million 63
Table Regional Demand Comparison List 64
Table Blood Product Demand Forecast 2020E-2025F, by End Users, in USD Million 65
Table Blood Product Production 2015-2020E, by Region, in USD Million 66
Figure North America Blood Product Market Size and Growth 2015-2020E, in USD Million 67
Table North America Blood Product Market Size 2015-2020E,by Country, in USD Million 67
Figure Europe Blood Product Market Size and Growth 2015-2020E, in USD Million 68
Table Europe Blood Product Market Size 2015-2020E,by Country, in USD Million 68
Figure Asia-Pacific Blood Product Market Size and Growth 2015-2020E, in USD Million 69
Table Asia-Pacific Blood Product Market Size 2015-2020E,by Country, in USD Million 69
Figure South America Blood Product Market Size and Growth 2015-2020E, in USD Million 70
Figure Middle East & Africa Blood Product Market Size and Growth 2015-2020E, in USD Million 71
Table South America and Middle East & Africa Blood Product Market Size 2015-2020E,by Country, in USD Million 71
Table Blood Product Market Forecast 2020E-2025F, by Region, in USD Million 72
Table Price Factors List 74
Table Gross Margin List 74
Figure Marketing Channels Overview 75


Tables and Figures



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets